tradingkey.logo
tradingkey.logo
Search

Mineralys Therapeutics Inc

MLYS
Add to Watchlist
25.520USD
-0.670-2.56%
Close 07-31 16:00ETQuotes delayed by 15 min
2.25BMarket Cap
LossP/E TTM

MLYS Financials

See Mineralys Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Mineralys Therapeutics Inc Earnings Date

Latest Release
May 6, 2026
EPS / Forecast
-0.47/-0.46
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.29
37.60%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
40.19%-0.47
59.49%-0.40
53.74%-0.52
20.44%-0.66
-13.15%-0.79
-61.20%-0.98
-98.43%-1.13
-172.10%-0.83
-127.40%-0.70
-148.19%-0.61
---0.57
---0.31
---0.31
---0.24
---0.56
----
----
----
Net Profit
6.80%-39.34M
34.14%-32.23M
34.45%-36.93M
-5.51%-43.27M
-33.97%-42.21M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-168.81%-24.39M
---22.76M
-87.39%-12.14M
-66.57%-12.61M
-28.10%-9.07M
----
---6.48M
---7.57M
---7.08M
Debt to assets ratio
----
----
----
----
----
----
--0.00%
----
----
--0.00%
----
--0.00%
--0.00%
--0.00%
----
----
----
----
Operating profit
-2.01%-45.34M
26.05%-38.28M
31.57%-41.13M
-3.49%-46.75M
-25.69%-44.45M
-86.81%-51.77M
-128.77%-60.11M
-187.05%-45.17M
-136.73%-35.36M
-176.89%-27.71M
---26.27M
-142.86%-15.73M
-97.36%-14.94M
-41.30%-10.01M
----
---6.48M
---7.57M
---7.08M
Net Profit
6.80%-39.34M
34.14%-32.23M
34.45%-36.93M
-5.51%-43.27M
-33.97%-42.21M
-100.69%-48.95M
-147.55%-56.34M
-237.81%-41.01M
-149.90%-31.51M
-168.81%-24.39M
---22.76M
-87.39%-12.14M
-66.57%-12.61M
-28.10%-9.07M
----
---6.48M
---7.57M
---7.08M
Current assets
84.05%652.47M
222.08%661.39M
124.03%599.80M
5.43%335.27M
2.22%354.51M
-17.56%205.35M
0.89%267.73M
18.00%318.00M
25.99%346.82M
120.81%249.10M
117.72%265.38M
--269.49M
--275.27M
--112.81M
--121.89M
----
----
----
Total current liabilities
9.95%14.72M
3.19%15.11M
-24.91%23.52M
-21.92%22.17M
-30.30%13.39M
39.73%14.65M
131.27%31.32M
357.50%28.40M
81.86%19.20M
29.94%10.48M
87.58%13.54M
--6.21M
--10.56M
--8.07M
--7.22M
----
----
----
Total assets
83.94%652.86M
221.42%661.81M
123.65%599.95M
5.41%335.72M
2.22%354.94M
-18.17%205.90M
-3.35%268.25M
9.37%318.49M
13.32%347.25M
119.88%251.64M
126.67%277.56M
--291.22M
--306.44M
--114.44M
--122.45M
----
----
----
Total liabilities
9.95%14.72M
3.19%15.11M
-24.91%23.52M
-21.92%22.17M
-30.30%13.39M
39.73%14.65M
131.27%31.32M
357.50%28.40M
81.86%19.20M
29.94%10.48M
87.58%13.54M
--6.21M
--10.56M
--8.07M
--7.22M
----
----
----
Total equity
86.83%638.14M
238.13%646.69M
143.29%576.43M
8.09%313.55M
4.12%341.56M
-20.69%191.26M
-10.26%236.93M
1.78%290.10M
10.87%328.05M
126.70%241.15M
129.12%264.01M
--285.01M
--295.88M
--106.38M
--115.23M
----
----
----
Net operating income
13.23%-39.47M
43.32%-37.89M
42.47%-28.87M
-0.08%-30.17M
-137.67%-45.49M
-130.64%-66.84M
-163.71%-50.19M
-47.88%-30.15M
-49.82%-19.14M
-184.52%-28.98M
---19.03M
-272.76%-20.39M
-94.21%-12.78M
-108.30%-10.19M
----
---5.47M
---6.58M
---4.89M
Net investment
51.61%-44.94M
-223.84%-103.49M
-289.07%-150.51M
-654.30%-42.88M
-65.99%-92.88M
1133.13%83.57M
1886.65%79.61M
147.93%7.74M
60.11%-55.95M
-116.18%-8.09M
--4.01M
---16.14M
---140.25M
--50.00M
----
--0.00
--0.00
----
Net financing
-87.18%24.27M
107345.56%96.70M
29518900.00%295.19M
6567.76%9.83M
62.88%189.28M
21.62%90.00K
-100.54%-1.00K
73.84%-152.00K
-42.92%116.20M
106.93%74.00K
--184.00K
-100.49%-581.00K
1596.85%203.57M
---1.07M
----
--117.65M
--12.00M
--0.00

FAQs

What are the current assets of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its current assets were 661.39M, with a year-on-year change of 222.08.

What are the total assets of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its total assets of Mineralys Therapeutics Inc were 661.81M, with a year-on-year change of 221.42.

What are the total liabilities of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its total liabilities of Mineralys Therapeutics Inc were 15.11M, with a year-on-year change of 3.19.

What is the total equity of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its total equity of Mineralys Therapeutics Inc was 646.69M, with a year-on-year change of 238.13.

What is the net operating income of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its net operating income of Mineralys Therapeutics Inc was -170.60M, with a year-on-year change of 11.33.

What is the net investment of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its net investment of Mineralys Therapeutics Inc was -389.75M, with a year-on-year change of -439.04.

What is the net financing of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its net financing of Mineralys Therapeutics Inc was 591.00M, with a year-on-year change of 408.86.

What is the Earnings Per Share (EPS) of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.29, with a year-on-year change of 37.60.

What is the net income of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its net income was -154.65M, with a year-on-year change of 13.02.

What is the Return on Equity (ROE) of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -36.91, with a year-on-year change of 55.12.

What is the Return on Assets (ROA) of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.65, with a year-on-year change of 54.14.

What is the operating profit of Mineralys Therapeutics Inc?

According to Mineralys Therapeutics Inc's FY2025 earnings report, its operating profit was -170.60M, with a year-on-year change of 11.33.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.